Follicopeptide is a premium peptide developed to promote natural hair growth and help maintain youthful hair. We plan to launch a cosmetic product line based on Follicopeptide, together with one or more partners, in key markets later this year.

The hair growth market has long lacked proven, effective solutions. With growing demand for products that support healthy ageing and vibrant, vital hair, Follicopeptide offers a scientifically backed innovation set to make a real difference.

Key benefits:

  • Clinically proven safety and efficacy
  • High responder rates (+70%)
  • Stimulates hair growth via a novel biological mechanism
  • Excellent skin compatibility – no reported irritation in trials
  • Suitable for both men and women, without prescription
  • Once daily application

The market

Hair loss affects both men and women. Data shows that as much as 50% of all adults globally suffer from hair loss during their lifetime. Currently, there are only a few products on the market that enhances hair growth. These have limited effect, only a small percentage of those who use the product respond to the treatment, they cannot be used by women in effective doses, and cause side effects such as impotence and hair growth in unwanted places.

When it comes to products that enhances eyelashes, Follicopeptide has great potential in the global market, especially since most of the leading products on the market contain prostaglandin analogues as the active component. The EU's Scientific Committee on Consumer Safety (SCCS) has announced its concerns about the safety of prostaglandin analogues when used in cosmetic products near the eye. The global market size for eyelash serum is estimated to 770 million US dollars and for eyebrows SEK 289 million US dollars.

The market for beard grooming products is growing rapidly due to an increased focus on personal care and the popularity of beards among men. In 2023, the market was valued at 240 billion SEK, but this figure encompasses all types of beard grooming products.

$8 billion

Estimated market value for hair products

$770 million

Estimated market value for eyelash serums

$289 million

Estimated market value for eyebrow serums

Road to launch

Follicopeptide is in the final stages of preparation for commercial launch in key regions. We’re currently evaluating packaging, distribution and go-to-market strategies, exploring partnerships focused on these regions.

Planned milestones for 2025:

  1. Cosmetic tests carried out
     
  2. Necessary permits obtained in key markets
     
  3. First commercial batch produced
     
  4. Licensing agreements with key commercial partners
     
  5. Product scale-up finalised
     
  6. Product launch in key markets
     

How it works

Follicopeptide is a modified segment of osteopontin – a natural human protein essential for healthy hair growth. It activates key processes in and around the hair follicle by stimulating stem cells, promoting new blood vessel growth, and supporting the surrounding tissue.

Androgenetic alopecia, the most common form of hair loss, occurs when hair follicles gradually miniaturise and become inactive, often due to reduced blood flow. Follicopeptide revitalises blood vessels around the follicle, enhancing growth and follicle health.

Follicopeptide

Progression of androgenic alopecia

Clinically validated

Clinical studies including more than 300 participants with androgenic alopecia demonstrated that Follicopeptide, applied once daily, resulted in remarkable growth of new hairs in individuals with a hair density of less than 255 hairs per square centimeter after just four months.

Background

Follicopeptide was developed by Professor Anna Hultgårdh Nilsson, Lund University in collaboration with LU Bioscience AB. Furthermore, Professor Jan Nilsson is active in progressing the mode-of-action of Follicopeptide at Lund University and in collaboration with Shanghai Changzheng Hospital, China.

Interested in partnering with us?

We welcome conversations with potential partners interested in bringing this innovation to their markets. Our flexible partnership models range from ingredient supply to ready-to-market formats. We’re actively exploring licensing, distribution and go-to-market strategies in key regions.

Get in touch